The result of this analysis is to determine the direct benefits from the use of drugs or the use of medical technology. Direct medical costs and outcomes are measured in monetary units. The result of the analysis of "cost - benefit" is to determine the direct benefits of the technology or drug. Currently, cost-benefit analysis is used only in conjunction with the methods of determining the CUA and called CEA. How called this pharmacoeconomic analysis